Actos Lawsuit Settlement News: Takeda's $2.37 Billion Settlement Endangerment Puts Actos Resolution at Risk, says Lawsuitsettlementnews.com

Lawsuit Help Center website reports that Takeda Pharmaceutical Co.'s $2.37 billion settlement over diabetes drug Actos didn't attract enough claimants to participate; deadline for claimants has now been pushed to September 11th

Aug 18, 2015, 05:00 ET from MT Services LLC

NEW ORLEANS, Aug. 18, 2015 /PRNewswire/ -- MT Services LLC, a Lawsuit Settlement News Reporting Company which operates lawsuitsettlementnews.com, announced today that Takeda Pharmaceutical Co.'s $2.37 billion settlement didn't attract enough claimants to participate in the deal, which said the company would fund the deal after 95% of claimants joined it. However, by the deadline last week, only approximately 75% had signed up, according to Bloomberg News, leading to doubts about whether or not the deal would ultimately survive. The deadline has now been pushed to September 11th for claimants to sign up for the settlement offer. The $2.37 billion settlement would result in settlement awards of more than $296,000 per case for plaintiffs who choose to participate in the settlement, but settlement amounts may be reduced depending on certain factors such as age, smoking history, and toxin exposure. Despite the settlement offer, Takeda denies Actos risks, and they are hoping to settle approximately 10K lawsuits against them of claims that Actos causes cancer.

The cases involved include approximately 3,500 lawsuits in Lafayette, Louisiana before U.S. District Judge Rebecca Doherty (In Re: Actos (Pioglitazone) Products Liability Litigation, 11-md-02299, U.S. District Court, Western District of Louisiana), and about 4,500 suits in California, Pennsylvania, Illinois, and West Virginia. Also according to Bloomberg, there are more cases "being held in abeyance while lawyers decide whether to add them to the settlement."

Chris Janish, CEO of MTS, commented on the recent news in the Actos settlement, "This is disappointing news for many Actos patients and their families who are in need of getting their settlement check this year. It now seems, at a minimum, that the settlement will be delayed and most payments will not be made until 2016."

MTS is able to help those who need lawsuit help with obtaining an Actos lawyer or Actos law firm to provide a free evaluation on their specific case. To learn more about MTS' services involving Actos and other bad drug litigations, please visit: http://www.lawsuitsettlementnews.com/actos-cases

If you already have an attorney and have filed a lawsuit and need a lawsuit funding cash advance or lawsuit money, not to be confused with a lawsuit loan or pre-settlement loan, Lawsuit Settlement News is here to assist you. Injured parties from Actos usage and/or complications can apply for up to $100K in pre-settlement or settlement lawsuit funding. For a full list of the services that the company provides, visit: http://www.lawsuitsettlementnews.com/about-our-products-and-services

If you, or a loved one, have suffered complications from Actos and need lawsuit money or lawsuit help, including finding an Actos attorney or law firm, please call 877.571.0405.

You may also fill out a quick application online at: www.lawsuitsettlementnews.com and an experienced agent will contact you shortly.

Disclaimer:  MT Services LLC, operator of Lawsuitsettlementnews.com, is not a law firm and cannot provide legal advice on your case; however, MTS works with lawyers involved in mass tort litigations who are willing to provide a free legal consultation at the consumer's request. For a list of full disclosures please visit the company's website disclosure page.

Contact:    Chris Janish, CEO
                Ph. 877.571.0405

SOURCE MT Services LLC



RELATED LINKS

http://www.lawsuitsettlementnews.com
http://www.lawsuitsettlementnews.com